Pharm. Melody Okereke
Nigeria does not lack knowledge about HIV. Over the years, researchers and healthcare professionals have generated strong evidence on what works. We know that antiretroviral therapy saves lives. We know that early diagnosis improves health outcomes. We know that prevention services can reduce new infections and that viral suppression helps people living with HIV live longer, healthier lives.
The challenge is no longer only discovering what works. The bigger challenge is making sure that what works reaches the people who need it, in the places where they need it, and in ways that fit their everyday realities. This is where implementation science becomes important.
Implementation science focuses on understanding how evidence-based interventions can be effectively delivered in real world settings. It asks questions that are often overlooked after a successful research study is completed.
Why does a programme that worked in one community struggle in another? Why do some patients start treatment but later disengage from care? Why do some healthcare workers adopt new guidelines quickly while others face difficulties? What changes are needed to make a health intervention sustainable?
These questions matter because healthcare does not happen in research papers. It happens in communities, clinics, homes, and everyday situations where people face different challenges.
Nigeria has made significant progress in its HIV response. The expansion of antiretroviral therapy has transformed the lives of many people living with HIV. Thousands of healthcare workers, community organisations, government agencies, and partners have contributed to improving access to prevention, testing, treatment, and care. However, important gaps remain.
A medicine can be available, but a patient may struggle to reach the clinic. A testing service may exist, but someone may avoid it because of stigma or fear of disclosure. A treatment programme may be effective, but patients may face challenges with transportation, cost, side effects, or social support that affect their ability to remain in care. These challenges are not signs that HIV interventions do not work. They show that the way interventions are delivered matters.
Implementation science helps us understand this gap between evidence and reality. For example, a clinical trial may show that a treatment is effective. However, after the treatment is introduced into routine healthcare, researchers still need to understand how it performs among different populations, within different health systems, and under real life conditions.
A patient receiving HIV care is not only managing a virus. They may also be managing family responsibilities, financial pressure, stigma, mental health challenges, or difficulties accessing healthcare services. These factors influence whether someone starts treatment, continues treatment, or achieves viral suppression.
This is why the HIV response must look beyond numbers. It is not enough to know how many people have been tested or started treatment. We must also understand who is being missed, why they are being missed, and what can be done differently.
Implementation science provides the tools to answer these questions. It helps researchers, healthcare providers, and policymakers identify barriers, test solutions, and improve programmes based on what is happening on the ground.
In Nigeria, this approach is particularly important because health challenges often vary across communities. A strategy that works well in an urban setting may require adjustments before it can succeed in rural or hard-to-reach communities. A programme designed for adults may need modification to effectively serve adolescents and young people. The people closest to the problem often have valuable insights into the solution.
Healthcare workers understand the challenges within health facilities. Community members understand the barriers affecting service access. Patients understand the realities of living with HIV. Implementation science brings these perspectives together to create programmes that are not only effective but also practical.
The future of Nigeria’s HIV response will depend on our ability to move beyond simply asking, “Does this intervention work?” We must also ask, “How can we make it work here?”
As Nigeria continues its efforts towards ending HIV as a public health challenge, implementation science will remain important in ensuring that scientific discoveries translate into better health outcomes. Research should not end when a study is published. Its true value is realised when it improves the lives of people.
The journey from research papers to real patients requires more than evidence alone. It requires understanding communities, strengthening health systems, listening to patients, and continuously improving the way care is delivered.
Because in the end, the success of Nigeria’s HIV response will not only be measured by the interventions we develop. It will be measured by the people.
- Okereke is a pharmacist and implementation science researcher working on harm reduction, HIV/AIDS programming, and health systems strengthening.